Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on May 6, 2025
Cellebrite anuncia su versión de mayo de 2025 para impulsar las investigaciones globales
GlobeNewswire
·
May 6, 2025
TYSONS CORNER, Virginia y PETAH TIKVA, Israel, May 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), un líder mundial en soluciones de investigación digital de primer nivel para los sectores público y privado, anunció hoy su versión de primavera 2025 …
Cellebrite apresenta Lançamento do Primeiro Semestre de 2025 para acelerar investigações globais
GlobeNewswire
·
May 6, 2025
TYSONS CORNER, Va. e PETAH TIKVA, Israel, May 06, 2025 (GLOBE NEWSWIRE) -- A Cellebrite DI Ltd. (Nasdaq: CLBT), líder global em soluções Investigativas Digitais dos setores público e privado, anunciou hoje seu lançamento do Primeiro Semestre de 2025, com …
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
GlobeNewswire
·
May 6, 2025
SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Netcoins Canada Provides Q1 2025 Results
GlobeNewswire
·
May 6, 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”) (TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, Blockchain Intelligence Group, …
Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update
GlobeNewswire
·
May 6, 2025
Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development …
Cellebrite dévoile sa version Printemps 2025 pour accélérer les enquêtes à l’échelle mondiale
GlobeNewswire
·
May 6, 2025
TYSONS CORNER, Virginie et PETAH TIKVA, Israël, 06 mai 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ : CLBT), leader mondial des solutions d’enquête numérique à destination des secteurs public et privé, annonce ce jour la sortie de sa version Printemps 2025, …
Orangekloud to Attend Directions ASIA 2025 Conference, May 7-9, in Bangkok
GlobeNewswire
·
May 6, 2025
SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (Nasdaq: ORKT) (“Orangekloud” or “the Company”), a pioneer in AI-driven no-code application development, today announced that the Company will be attending the Directions ASIA 2025 …
Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US
GlobeNewswire
·
May 6, 2025
WARRINGTON, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …
Atsign Supercharges File Sharing with Invisible SMB/CIFS Connections
GlobeNewswire
·
May 6, 2025
SAN JOSE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Atsign, the leader in invisible zero trust connectivity solutions, today announced that its NoPorts technology now supports invisible SMB/CIFS connections. This breakthrough enables users to access file …
FOXO TECHNOLOGIES INC.’S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES
GlobeNewswire
·
May 6, 2025
WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has reached key patient care milestones. …
IMUNON Announces Data from Phase 1/2 Trial Evaluating Intraperitoneal IMNN-001 in Combination with Neoadjuvant Chemotherapy in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer to be Published in Gynecologic Oncology
GlobeNewswire
·
May 6, 2025
Data from OVATION 2 trial will also be reviewed in an oral presentation at ASCO Annual Meeting on June 3, 2025 LAWRENCEVILLE, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its …
Candel Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
NEEDHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, …
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference
GlobeNewswire
·
May 6, 2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Digital Cameras Big Savings Alert: Save on Nikon, Canon, and Sony Flagship Cameras for a Limited Time, Top Camera Deals Now Live at B&H Photo
GlobeNewswire
·
May 6, 2025
Photography enthusiasts and professionals alike can now take advantage of some of the industry’s most coveted cameras. B…
Great Lakes Reports First Quarter 2025 Results
GlobeNewswire
·
May 6, 2025
First quarter net income of $33.4 million First quarter Adjusted EBITDA of $60.1 million Dredging backlog of $1 billion at March 31, 2025 HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Great Lakes Dredge …
Boehringer Ingelheim starts Phase II study of its potential first-in-class oral compound as a treatment for Geographic Atropy
GlobeNewswire
·
May 6, 2025
Ingelheim, Germany, May 6, 2025 – Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential first-in-class treatment for geographic atrophy (GA).[1 …
Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 6, 2025
NXP900 clinical data presentation from the Phase 1a dose escalation study at the 2025 American Association for Cancer Research (AACR) conference demonstrated robust pharmacodynamic response and acceptable safety at clinically relevant doses; preclinical …
AMRT Satellite Technology Uncovers Significant Mineral Assets at Historic Oregon Mine
EIN Presswire
·
May 6, 2025
Abandoned Mine Expected to Roar Back to Life with Massive Results thanks to AMRT Satellite Scan Technology MESA, AZ, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- CC Explorations, a leading satellite-based mineral exploration company, today announced …
R3 Stem Cell Opens First Rate New Clinic in Puerto Vallarta Mexico
EIN Presswire
·
May 6, 2025
R3 Stem Cell is now treating patients at a new clinic in Puerto Vallarta Mexico. The clinic offers a full slate of first rate stem cell and exosome therapies. SCOTTSDALE, AZ, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- R3 Stem Cell announced today …
ReportAId raises €2.2M using AI to unlock healthcare data
GlobeNewswire
·
May 6, 2025
Milan, May 06, 2025 (GLOBE NEWSWIRE) -- Ask any doctor what's keeping them from delivering better care, and paperwork will top the list. Despite billions invested in healthcare technology, 80% of clinical data remains trapped in unstructured reports, and …